Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Jazz Pharmaceuticals (JAZZ)

JAZZ RSS Feed
Add JAZZ Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 12/9/2014 8:36:50 AM - Followers: 17 - Board type: Free - Posts Today: 0



Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients' lives. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success.
 

MISSION & VALUES

MISSION

Our mission is to improve patients' lives by identifying, developing and commercializing important specialty pharmaceutical products to address unmet patient needs. We address serious diseases, always with the goal of improving patient care. Keeping patients at the forefront of our mind inspires us to bring innovative and valuable resources to all aspects of our business for the ultimate benefit of the patients in need.

CORE VALUES

Our core values define our corporate practices and demonstrate our commitment to improving patients' lives.

INTEGRITY

We value honesty and compliance with all of the laws, rules, regulations and corporate policies that apply to our business, and we expect the same total commitment from our employees, consultants, business partners and service providers. We view our uncompromising commitment to honesty and compliance as a core value - one that we look for in all of our employees.

COLLABORATION

Like the talented musicians who inspired our company name, we believe that the whole is much greater than the sum of its parts. Jazz musicians are known for working together to create new and exciting riffs or new variations on familiar themes. Similarly, the hallmark of our collaborative spirit is our ability to work together in creative teams to accomplish not only research and development goals, but also commercial and corporate objectives. Our value of and respect for one another support our collaboration on projects to help patients, patient advocates and our community.

PASSION

Our passion is our unwavering commitment to improving patient care. The intensity we devote to our efforts and our focus on the efficient development of products to address unmet patient needs are clear evidence of our passion.

INNOVATION

Innovation is essential to help patients and health care providers address unmet medical needs. Striving to provide new benefits for unmet patient needs requires us to look for novel solutions, particularly where others have been discouraged by the difficulty of the problem or the small size of the patient population.

PURSUIT OF EXCELLENCE

In all that we do - our passion and collaboration, our integrity and our caring for patients - we demonstrate our pursuit of excellence. We will always strive to take it to the next level.
 

WHAT'S IN A NAME?

The name "Jazz Pharmaceuticals" was inspired by the talented jazz musicians who come together - each a musical specialist with an individual style - to make music in concert that is greater than the sum of its parts. Jazz musicians are known for working together to create new and exciting riffs or new variations on familiar themes. Jazz music showcases the coexistence of improvisation and structure.

At Jazz Pharmaceuticals, we believe that each member of our team makes integral contributions working toward a common goal to improve patients' lives. The hallmark of our collaborative spirit is our ability to work together in creative teams to accomplish not only research and development goals, but also commercial and corporate objectives.
 

PRODUCTS

At Jazz Pharmaceuticals, our mission is to improve patients' lives by identifying, developing and commercializing products including: XYREM, ERWINAZE, PRIALT, FAZACLO LD and HD and LUVOX CR. The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD and HD and LUVOX CR is intended only for residents of the United States. Click on the logos below to view complete prescribing information, including boxed warnings.

In addition to these products marketed in the U.S., EUSA Pharma, an international division of Jazz Pharmaceuticals, markets products outside of the U.S. in more than 80 countries. For more information please visit: www.EUSAPharma.com.

To report an adverse event or a product complaint, or to request information about our products, please click here.

NARCOLEPSY
ONCOLOGY
PSYCHIATRY
PAIN
OTHER

RESEARCH & DEVELOPMENT

Jazz Pharmaceuticals has an unwavering commitment to improving care for patients with serious medical conditions through innovative treatments. We are working to expand our current portfolio of commercial products through targeted investments in post-discovery research and development. We are working closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals' approach to patient care may be able to help solve problems in a unique way that will make a substantive difference for patients.

Our long-term vision includes building a development pipeline that could offer potential new treatment options for patients. Our current research and development efforts include programs to improve the current products in our oncology and psychiatry franchises, as well as other development opportunities that support our mission to improve patient's lives.

PIPELINE

ErwinazeTM/Erwinase©

(asparaginase Erwinia
chrysanthemi)

  • IV formulation in development
  • Exploring additional labeling opportunities

Leukotac®

(inolimomab)

  • Anti-CD25 monoclonal antibody
  • Treatment of steroid-refractory acute graft vs. host disease
  • EU Phase III study underway

Asparec®

(mPEG-r-crisantaspase)

  • Pegylated recombinant erwinia asparaginase
  • E. Coli asparaginase hypersensitivity
  • Currently in Phase I development in EU

Clozapine

  • Oral dosing formulation, for which an NDA has been submitted to
    the FDA
  • Additional formulations to provide potential new dosing options to patients and physicians
  • Once daily formulation undergoing evaluation

 

LOCATIONS

CORPORATE HEADQUARTERS  
Fourth Floor, Connaught House,
One Burlington Road, Dublin 4,
Ireland
Phone: +353.1.634.7800
Fax: +353.1.634.7850
   
U.S. LOCATIONS  

3180 Porter Drive
Palo Alto, CA 94304
Phone: 650.496.3777
Fax: 650.496.3781

1818 Market Street, Suite 2350
Philadelphia, PA 19103
Phone: 215.832.3750
Fax: 215.832.3789

One Summit Square
1717 Langhorne-Newtown Road
Suite 201
Langhorne, PA 19047
Phone: 215.867.4900
Fax: 215.579.0384
INTERNATIONAL DIVISION

EUSA Pharma International Headquarters
Oxford UK office
The Magdalen Centre
Oxford Science Park
Oxford, OX4 4GA
www.EUSAPharma.com



Analysts

Firm Analyst
Bank of America Merrill Lynch Gregg Gilbert
Barclays Capital Douglas Tsao
Brean Murray Carret & Co. Gene Mack
Cantor Fitzgerald Irina Rivkind
Citi Jonathan Eckard, Ph.D.
Cowen & Co. Ken  Cacciatore
Discern Patricia Bank
Guggenheim Louise Chen
Jefferies & Company Corey Davis, Ph.D.
Lazard Capital Markets William Tanner, Ph.D.
Leerink Swann Michael Schmidt, Ph.D.
Oppenheimer Christopher Holterhoff
Piper Jaffray David Amsellem
UBS Ami Fadia
Wallach Beth Capital, LLC Difei  Yang, Ph.D.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
JAZZ
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for JAZZ
JAZZ News: Statement of Changes in Beneficial Ownership (4) 12/16/2014 04:05:29 PM
JAZZ News: Statement of Changes in Beneficial Ownership (4) 12/11/2014 06:25:55 PM
JAZZ News: Statement of Changes in Beneficial Ownership (4) 12/11/2014 06:09:59 PM
JAZZ News: Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Dise... 12/11/2014 04:05:00 PM
JAZZ News: Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update 12/09/2014 08:30:00 AM
PostSubject
#244   *DJ Jazz Pharmaceuticals: Phase 1 Clinical Data Generated UserAlias1 12/09/14 08:36:50 AM
#243   $JAZZ NEWS: Jazz Pharmaceuticals and Concert Pharmaceuticals Provide UserAlias1 12/09/14 08:34:05 AM
#242   $JAZZ Cantor Raises Jazz Pharmaceuticals Price Target On maytepper 11/03/14 11:12:05 AM
#241   I am told JAZZ is turned out to Setay 11/02/14 05:50:26 AM
#240   For some reason I am very partial to jazz_1 10/16/14 03:03:17 PM
#239   $JAZZ $FLML Canaccord Provides Input Into Jazz’s Patent maytepper 10/03/14 05:25:03 PM
#238   Loved it entered with entered fri the $165.00 Skitradr 09/10/14 09:26:05 AM
#237   Got out of this Monday when she hit 171... Skitradr 09/10/14 09:22:21 AM
#235   lolzzz, I really did use it a lot Lotto123 09/05/14 10:46:59 PM
#234   That's funny.......just found one of you're old post Skitradr 09/05/14 09:55:22 PM
#233   Buy point at $165+....nice..... dammmm, I haven't done Lotto123 09/05/14 09:43:54 PM
#232   This sure doesn't hurt the cause ....... Skitradr 09/05/14 09:27:10 PM
#231   Nice ......this one's been very nice to me Lotto123 09/05/14 08:37:04 PM
#230   I agree.....picked up some sept 20th $ 165.00 Skitradr 09/05/14 07:59:54 PM
#229   JAZZ Nice day....weeeeeeeeeeeeeeeeeeeee... Lotto123 09/05/14 07:27:34 PM
#228   You still holding this treasure? :-) Lotto123 08/29/14 05:39:24 PM
#227   Double top or breakout coming... ;-) Lotto123 08/29/14 05:36:39 PM
#226   JAZZ crankin' again... weeeeeeeeeeeeee... Lotto123 08/29/14 05:06:33 PM
#225   JAZZ - My personal gift from God... :-D Lotto123 08/20/14 08:59:06 AM
#224   Cantor Fitzgerald Reiterates Hold On Jazz Pharmaceuticals Following maytepper 08/08/14 11:42:43 AM
#223   AMBS is a Sham... Look at the BS expediter13 07/21/14 06:54:13 AM
#222   Ripe for inversion....cheap price considering... Lotto123 06/28/14 12:24:51 AM
#221   WSJ: http://blogs.wsj.com/pharmalot/2014/06/20/a-look-at-the-european-pharmaceut Lotto123 06/28/14 12:20:46 AM
#220   Triggered out on dip...Loading back up first sign.. ;-) Lotto123 06/28/14 12:05:58 AM
#219   LOLZZZZZZ....Not sure who is still around....I loaded up Lotto123 06/19/14 11:56:27 PM
#217   Just curious. I am from another board (almost longboardsurfer90210 06/01/14 03:40:54 PM
#216   lol, funny to read old comments like this JojoK 05/25/14 12:18:22 AM
#215   $JAZZ: Broke below Major Support..... bsdvs23 04/29/14 07:29:12 AM
#214   $JAZZ: Could be intraday topping here.... bsdvs23 04/07/14 02:45:49 PM
#213   $JAZZ: Continuing its Lower Highs and Lower Lows..... bsdvs23 04/07/14 12:05:05 PM
#212   nope!!! crushing through every resistance level now! Mithrandir67 04/04/14 12:26:43 PM
#211   looks like it's coming back! Mithrandir67 04/01/14 10:15:08 AM
#210   Apparently also overpriced was Celgene, Regeneron, Gilead, Isis dispoman 03/31/14 08:01:12 AM
#209   I see the next major support around 126 Mithrandir67 03/27/14 09:57:25 AM
#208   downward trend still intact I would say - Mithrandir67 03/25/14 02:58:44 PM
#207   $JAZZ: Loading Bounce 135 IMO bsdvs23 03/23/14 02:12:06 AM
#206   $JAZZ: Next Major Support @ 130 bsdvs23 03/16/14 09:46:05 PM
#205   falling knife again? Mithrandir67 03/06/14 01:57:57 PM
#204   $JAZZ: Gap Filled..... bsdvs23 03/04/14 10:03:45 AM
#203   $JAZZ: Breakout Morning Gap.... bsdvs23 03/04/14 09:34:07 AM
#202   $JAZZ: Great Turnout Today..... Now Let's bsdvs23 03/03/14 03:48:04 PM
#201   $JAZZ: Breakout... Bullish Reversal $$$$ bsdvs23 03/03/14 12:37:43 PM
#200   $JAZZ: NHOD - MOMO & Money Volume Increasing... bsdvs23 03/03/14 12:33:29 PM
#199   $JAZZ: Intraday MOMO building.... bsdvs23 03/03/14 12:00:16 PM
#198   it's not done yet with the pps pull Mithrandir67 03/03/14 11:13:23 AM
#197   $ JAZZ: LOOKING for bounce here! B! bsdvs23 03/02/14 02:21:51 AM
#196   $JAZZ: FAILING KNIFE!! bsdvs23 02/28/14 03:18:24 PM
#195   JAZZ just came out with a nice Q4 Steponit 02/25/14 05:06:25 PM
#194   so, looking forward to the 25th then - Mithrandir67 02/12/14 10:06:56 AM
#193   well, the continuous climb is definately over:-( Mithrandir67 02/10/14 01:38:06 PM
PostSubject